GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Flora Growth Corp (FRA:7301) » Definitions » EV-to-EBITDA

Flora Growth (FRA:7301) EV-to-EBITDA : -1.37 (As of May. 31, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Flora Growth EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Flora Growth's enterprise value is €16.48 Mil. Flora Growth's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was €-12.06 Mil. Therefore, Flora Growth's EV-to-EBITDA for today is -1.37.

The historical rank and industry rank for Flora Growth's EV-to-EBITDA or its related term are showing as below:

FRA:7301' s EV-to-EBITDA Range Over the Past 10 Years
Min: -149.33   Med: -1.32   Max: -0.23
Current: -1.45

During the past 6 years, the highest EV-to-EBITDA of Flora Growth was -0.23. The lowest was -149.33. And the median was -1.32.

FRA:7301's EV-to-EBITDA is ranked worse than
100% of 735 companies
in the Drug Manufacturers industry
Industry Median: 13.98 vs FRA:7301: -1.45

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-31), Flora Growth's stock price is €0.56. Flora Growth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.914. Therefore, Flora Growth's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Flora Growth EV-to-EBITDA Historical Data

The historical data trend for Flora Growth's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flora Growth EV-to-EBITDA Chart

Flora Growth Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial - -3.83 -1.41 -0.25 -1.19

Flora Growth Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.64 -1.14 -1.32 -1.19 -1.19

Competitive Comparison of Flora Growth's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Flora Growth's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Flora Growth's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Flora Growth's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Flora Growth's EV-to-EBITDA falls into.


;
;

Flora Growth EV-to-EBITDA Calculation

Flora Growth's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=16.478/-12.056
=-1.37

Flora Growth's current Enterprise Value is €16.48 Mil.
Flora Growth's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-12.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Flora Growth  (FRA:7301) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Flora Growth's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.56/-0.914
=At Loss

Flora Growth's share price for today is €0.56.
Flora Growth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.914.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Flora Growth EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Flora Growth's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Flora Growth Business Description

Traded in Other Exchanges
Address
3230 W. Commercial Boulevard, Suite 180, Fort Lauderdale, FL, USA, 33309
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.

Flora Growth Headlines

No Headlines